Campus Map | Phonebook | Calendars | A-Z Index

Jan Egan
PhD Candidate
Cancer Biology GIDP


American Association for Cancer Research Annual Meeting 2008
San Diego, California
April 12-16, 2008

“Vitamin D and APC Modulate Molecular Crosstalk between β-catenin/Wnt Signaling and the Vitamin D Receptor in Colon Cancer Cells”



ABSTRACT

Vitamin D is implicated as a protective factor in human colon carcinogenesis. Anti-tumor activity of vitamin D on colonocytes is thought to be mediated by 1,25(OH)2D3, the active hormonal metabolite of vitamin D. We examined the role of vitamin D on a putative VDR/ β-catenin interaction. We first sought to confirm that VDR associates physically with β-catenin regulating critical Wnt signaling events in colon tumorigenesis. Second, we assessed the role of the intact and mutant adenomatous polyposis coli (APC) gene, commonly dysregulated in human colon cancers, as a modulator of the VDR/ β-catenin interaction. Third, we investigated the role of germline allele variation in APC as potential commonly occurring gene modifiers of individual susceptibility for the formation of colorectal adenomas. Glutathione-S-transferase (GST) pulldown assays and an in-vitro transcription/translation system to produce β-catenin protein support an interaction between β-catenin and VDR that appears independent of 1,25(OH)2D3. Further evaluation of this interaction within the cell using a mammalian two hybrid system in transfected HT29-APC, a cell line which allows inducible wildtype APC protein, suggest that APC positively influences the interaction between β-catenin and VDR, and that this association is enhanced at least 6-fold in the presence of 1,25(OH)2D3. To determine the functional significance of VDR and 1,25(OH)2D3 on the transcriptional activity of β-catenin, a TOPflash assay is being implemented in HT-29 cells. Thus, our biochemical results support the presence of a VDR and β-catenin interaction that occurs independent of 1,25(OH)2D3 and that appears to be significantly enhanced in the presence of both the hormone and intact APC. In an effort to determine if polymorphic variation in APC influenced risk of colorectal neoplasia, haplotype analyses of single nucleotide polymorphisms located in APC were assessed for their relationship with colorectal adenoma recurrence. A strong association (OR = 0.74, 95% CI = 0.59 – 0.92) was observed for a T-A haplotype subgroup and risk of recurrent adenoma. Overall, the data represents a novel crosstalk mechanism whereby 1,25(OH)2D3-VDR and APC could negatively regulate the Wnt signaling pathway to restrict tumorigenesis. Furthermore, genetic variation in APC may alter the efficiency of the interaction of this complex resulting in variable risk of adenoma recurrence among individual.

© The Arizona Board of Regents. All Contents Copyrighted. All Rights Reserved. | Privacy Statement